Great Point Partners’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCRX
ECM
Great Point Partners's OCRX Position: Q1 2017 in Review
Great Point Partners sold out of Ocera Therapeutics (OCRX) in Q1 2017, closing a stake of 1,963,777 shares — an estimated $4.12M sold.
Great Point Partners first reported a position in OCRX in Q4 2013 and held it in 13 quarters. The position peaked at $12.5M in Q4 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.
- Great Point Partners reported no remaining Ocera Therapeutics position as of Q1 2017 after selling out during the quarter.
- Great Point Partners sold 1,963,777 Ocera Therapeutics shares in Q1 2017, an estimated $4.12M.
- Great Point Partners first reported a position in Ocera Therapeutics in Q4 2013 and held it in 13 quarters.
- Great Point Partners's Ocera Therapeutics position peaked at $12.5M in Q4 2014.
- 26 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q1 2017.
Based on Great Point Partners's 13F filing for Q1 2017, filed 15 May 2017.